Forecast & RatingOnly 1 analyst currently covers IX Biopharma (42C.SG), with a price target of S$1.00 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Sep 8, 2026; this does not constitute investment advice.
Sep 7, 2026Price forecast
S$1.0076.99%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 20, 2026
Forecast met0.0%
Stock price$0.57
Avg. target$1.0
High target$1
Low target$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.